MP58-16 SGLT2-INHIBITOR USAGE AND INCIDENCE OF FOURNIER′S GANGRENE
2020
INTRODUCTION AND OBJECTIVE:In May 2019, the Food and Drug Administration (FDA) issued a Black Box Warning against sodium-glucose cotransporter-2 inhibitor (SGLT2) antihyperglycemic medications, cit...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI